Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
8260591 | Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease | 2013 | 7 Pages |
Abstract
NF-κB is an important regulator of immunity and inflammation, and its activation pathway has been studied extensively. The mechanisms that downregulate the activity of NF-κB have also received a lot of attention, particularly since its activity needs to be terminated to prevent chronic inflammation and subsequent tissue damage. The COMMD family has been identified as a new group of proteins involved in NF-κB termination. All ten COMMD members share the structurally conserved carboxy-terminal motif, the COMM domain, and are ubiquitously expressed. They seem to play distinct and non-redundant roles in various physiological processes, including NF-κB signaling. In this review, we describe the mechanisms and proteins involved in the termination of canonical NF-κB signaling, with a specific focus on the role of the COMMD family in the down-modulation of NF-κB.
Keywords
RIP1IKKNLSHIFTLR4RHDCRLCrm1TRAFXIAPTNFAIP3IL-1RDUBPIASPDLIM2SCLUCullin RING ligaseTNFRBxTAKRING box proteinNF-κBnESLPSIL-1SOD1CFTRHDACPMLIκBENaCIκB kinasedeubiquitinating enzymeinflammationinterleukin-1TADTerminationScaffoldtransactivation domainRel homology domaincystic fibrosis transmembrane conductance regulatorsuperoxide dismutase 1CyldCylindromatosisnuclear export signalnuclear localization signalHypoxia Inducible Factortumor necrosis factornuclear factor κBlipopolysaccharideinhibitor of κBX-linked inhibitor of apoptosisprotein inhibitor of activated Stathistone deacetylasereceptor-interacting protein 1Promyelocytic leukemia proteinSingle nucleotide polymorphismSNPepithelial sodium channelinterleukin-1 receptorToll-like receptor 4
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Ageing
Authors
Paulina Bartuzi, Marten H. Hofker, Bart van de Sluis,